Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHilton Foods Regulatory News (HFG)

Share Price Information for Hilton Foods (HFG)

Share Price is delayed by 15 minutes
Get Live Data
521.50    4.00 (0.77%)
Bid:
520.00
Ask:
521.00
Spread: 1.00 (0.192%)
Market Cap: £469.12m
HFG Live PriceLast checked at - London Stock Exchange

Intraday Hilton Foods Share Chart

Holding(s) in Company

16 Dec 2009 17:54

RNS Number : 2634E
Hilton Food Group PLC
16 December 2009
Β 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:Β ii

Hilton Food GroupΒ plc

2 Reason for the notificationΒ (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal ofΒ qualifyingΒ financial instruments which may result in theΒ acquisition of shares already issuedΒ to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rightsΒ 

Other (please specify):

3. Full name of person(s) subject to the notification obligation:Β iii

Aviva plc & its subsidiaries

4. Full name of shareholder(s)Β Β (if differentΒ from 3.):iv

Registered Holder:

BNY Norwich Union Nominees Limited 281,584*

ChaseΒ (GA Group)Β Nominees Limited 1,700,539*

Chase Nominees Limited 118,314*

CUIM Nominee Limited 19,052*

*denotes direct interest

5. Date of the transaction and date on which the threshold is crossed or reached:Β v

15 DecemberΒ 2009

6.Β Date on which issuer notified:

16 DecemberΒ 2009

7. Threshold(s) that is/are crossed or reached:Β vi, vii

<3% toΒ 3% Change atΒ DirectΒ InterestΒ Level

8. Notified details:

A: Voting rights attached to sharesΒ viii, ix

Class/type of shares

if possible using the ISIN CODE

Situation previous to theΒ triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rightsΒ x

Direct

DirectΒ xi

IndirectΒ xii

Direct

Indirect

Ordinary Shares

GB00B1V9NW54

1,954,489

1,954,489

2,119,489

2,119,489

Not Disclosable

3.04%

Not Disclosable

B:Β QualifyingΒ Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration dateΒ xiii

Exercise/Β Conversion PeriodΒ xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C:Β FinancialΒ Instruments with similar economic effect to QualifyingΒ FinancialΒ InstrumentsΒ xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration dateΒ xvii

Exercise/ Conversion periodΒ xviii

Number of voting rights instrument refers to

% of voting rightsΒ xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

PercentageΒ of voting rights

2,119,489

3.04%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:Β xxi

The voting rights are managed and controlled byΒ Aviva Investors Global Services Limited,Β with the following chain of controlled undertakings:-

Aviva Investors Global Services Limited:

Aviva plc (Parent Company)

Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

Aviva Investors Holdings LimitedΒ (wholly owned subsidiary of Aviva Group Holdings Limited)

Aviva Investors Global ServicesΒ Limited (wholly owned subsidiary ofΒ Aviva Investors HoldingsΒ Limited)

Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Figures are based on a total number of voting rights ofΒ Β 69,656,667.

14. Contact name:

Neil Whittaker

15. Contact telephone number:

01603 684420

Note:Β Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full nameΒ 

(including legal form of legal entities)

Contact addressΒ 

(registered office for legal entities)

Phone numberΒ & email

Other useful informationΒ 

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Contact address

Phone numberΒ & email

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLTFBRTMMABBBL
Date   Source Headline
16th Jun 20267:00 amRNSDirectorate change
27th May 20268:22 amRNSDirectorate change
19th May 20264:00 pmRNSResult of AGM
19th May 20267:00 amRNSAGM Trading Update
28th Apr 20264:54 pmRNSHolding(s) in Company
16th Apr 20266:01 pmRNSAnnual Financial Report & Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20263:53 pmRNSHolding(s) in Company
31st Mar 20267:01 amRNSDirectorate change
31st Mar 20267:00 amRNSPreliminary Results
2nd Feb 20267:00 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNS2025 Full Year Trading Update
8th Jan 20267:00 amRNSBoard and Senior Leadership Changes
2nd Jan 202612:25 pmRNSTotal Voting Rights
2nd Jan 202612:19 pmRNSBlock listing Interim Review
2nd Dec 20252:14 pmRNSNotification of Dealing Form
25th Nov 20257:00 amRNSDirectorate Change
13th Nov 20254:02 pmRNSHolding(s) in Company
12th Nov 20257:00 amRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
23rd Oct 20257:00 amRNSNotification of major holdings
10th Oct 20252:39 pmRNSDirector/PDMR Shareholding
1st Oct 20256:30 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSSale of Fairfax Meadow Europe Limited
3rd Sep 20257:00 amRNSInterim Results
6th Aug 20253:19 pmRNSHolding(s) in Company
5th Aug 20252:43 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSStrategic External Investment
14th Jul 20252:50 pmRNSAdditional Listing
2nd Jul 20259:50 amRNSBlock listing Interim Review
20th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20253:26 pmRNSHolding(s) in Company
27th May 20252:22 pmRNSDirector/PDMR Shareholding
20th May 20253:57 pmRNSResult of AGM
20th May 20257:00 amRNSBoard Changes
20th May 20257:00 amRNSAGM Trading Update
13th May 20253:44 pmRNSDirector/PDMR Shareholding
6th May 20253:15 pmRNSTotal Voting Rights
28th Apr 20259:36 amRNSHolding(s) in Company
23rd Apr 20255:16 pmRNSDirector/PDMR Shareholding
22nd Apr 20251:56 pmRNSAnnual Financial Report
8th Apr 20253:48 pmRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSPreliminary Results
6th Mar 20257:00 amRNSChange in Senior Independent Director
6th Mar 20257:00 amRNSHILTON FOODS SIGNS JOINT VENTURE WITH NADEC
26th Feb 20254:14 pmRNSHolding(s) in Company
29th Jan 20253:21 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSFull Year Trading Update
2nd Jan 202511:51 amRNSBlock listing Interim Review
2nd Jan 202511:47 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.